DalsnaFinance › IPOs › Pliant Therapeutics › IPO
PLIANT THERAPEUTICS, INC. completed its initial public offering on NASDAQ on June 3, 2020, pricing at $16.00 a share.
| Ticker | PLRX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 3, 2020 |
| Offering price | $16.00 |
| Shares offered | 9,000,000 |
| Total raised | $144M |
PLIANT THERAPEUTICS, INC. sold 9,000,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $144 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $144 million total recorded for the deal.
PLIANT THERAPEUTICS, INC. — quote, profile and latest news →
Source: SEC EDGAR filings for PLIANT THERAPEUTICS, INC.. This page is general information, not investment advice.